Picture of PDS Biotechnology logo

PDSB — PDS Biotechnology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

PDS Biotechnology Corp reports results for the quarter ended in March - Earnings Summary

* PDS Biotechnology Corp  PDSB.OQ  reported a quarterly
adjusted
loss of 30 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -32 cents.  The mean expectation of six analysts
for the quarter was for a loss of 37 cents per share. Wall
Street expected results to range from -45 cents to -28 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * PDS Biotechnology Corp's reported EPS for the quarter was
a loss
of 30 cents​.
    * The company reported a quarterly loss of $10.6 million.
    * PDS Biotechnology Corp shares had fallen by 10.7% this
quarter and lost 28.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 16.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for PDS Biotechnology
Corp is $17.00 
This summary was machine generated from LSEG data May 15 at
02:51 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.37          -0.30          Beat
 Dec. 31 2023      -0.44          -0.35          Beat
 Sep. 30 2023      -0.45          -0.35          Beat
 Jun. 30 2023      -0.35          -0.37          Missed

Recent news on PDS Biotechnology

See all news